Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Baillie

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Pharmacological Reviews|June 1, 1981
The use of stable isotopes in pharmacological researchT A Baillie
Pharmaceutisch Weekblad. Scientific Edition|June 19, 1992
Metabolism of valproate to hepatotoxic intermediatesT A Baillie
Chemical Research in Toxicology|July 1, 1988
Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acidT A Baillie
Advances in Experimental Medicine and Biology|January 5, 2002
Biological reactive intermediates in drug discovery and development: a perspective from the pharmaceutical industryT A Baillie, K Kassahun
The American Journal of Gastroenterology|September 1, 1992
Re:Incidental microvesicular steatosis due to valproic acid anticonvulsant therapyJ Baillie, T A Baillie
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Reversibility in glutathione-conjugate formationT A Baillie, K Kassahun
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparationsK Kassahun, T A Baillie
Chemical Research in Toxicology|March 1, 1997
Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in ratsL Jin, T A Baillie
FEBS Letters|October 15, 1975
Role of the site of sulpho-conjugation on the formation of hydroxylated corticosterone metabolites in the ratT A Baillie, H Eriksson
Biomedical Mass Spectrometry|July 1, 1984
Evidence for the in vitro metabolism of allylisopropylacetamide to reactive intermediates. Mechanistic studies with oxygen-18K S Prickett, T A Baillie
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Pharmacological Reviews|June 1, 1981
The use of stable isotopes in pharmacological researchT A Baillie
Pharmaceutisch Weekblad. Scientific Edition|June 19, 1992
Metabolism of valproate to hepatotoxic intermediatesT A Baillie
Chemical Research in Toxicology|July 1, 1988
Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acidT A Baillie
Advances in Experimental Medicine and Biology|January 5, 2002
Biological reactive intermediates in drug discovery and development: a perspective from the pharmaceutical industryT A Baillie, K Kassahun
The American Journal of Gastroenterology|September 1, 1992
Re:Incidental microvesicular steatosis due to valproic acid anticonvulsant therapyJ Baillie, T A Baillie
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Reversibility in glutathione-conjugate formationT A Baillie, K Kassahun
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparationsK Kassahun, T A Baillie
Chemical Research in Toxicology|March 1, 1997
Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in ratsL Jin, T A Baillie
FEBS Letters|October 15, 1975
Role of the site of sulpho-conjugation on the formation of hydroxylated corticosterone metabolites in the ratT A Baillie, H Eriksson
Biomedical Mass Spectrometry|July 1, 1984
Evidence for the in vitro metabolism of allylisopropylacetamide to reactive intermediates. Mechanistic studies with oxygen-18K S Prickett, T A Baillie
Pageof 13